CSTIBOSAN B48 - LIQ
CSTIBOSAN B48 - LIQ
Discontinued
DIN Number
02158922
Drug Class
Human
Market Date
Dec 31, 1996
Company
HC
professional health products
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02158922
AIG Number1127521001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification
ACTIVE INGREDIENTS (11)
APIS MELLIFICAActive
Strength: 3 D / ML
Monograph: APIS MELLIFICA
APOCYNUM ANDROSAEMIFOLIUMActive
Strength: 3 D / ML
Monograph: APOCYNUM ANDROSAEMIFOLIUM
BARBERRY ROOTActive
Strength: 3 D / ML
Monograph: BARBERRY ROOT
BENZOIC ACIDActive
Strength: 4 D / ML
Monograph: BENZOIC ACID
GOLDENRODActive
Strength: 2 D / ML
Monograph: GOLDENROD
LYCOPODIUMActive
Strength: 3 D / ML
Monograph: LYCOPODIUM
POTASSIUM CARBONATEActive
Strength: 2 D / ML
Monograph: POTASSIUM CARBONATE
SAW PALMETTOActive
Strength: 2 D / ML
Monograph: SAW PALMETTO
SQUILLActive
Strength: 3 D / ML
Monograph: SQUILL
TURPENTINEActive
Strength: 5 D / ML
Monograph: TURPENTINE
UVA URSIActive
Strength: 2 D / ML
Monograph: UVA URSI